Steris Widens FY2027 Adj EPS Guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 Est; Affirms FY2027 Sales Guidance of $6.352B-$6.411B vs $6.371B Est

Benzinga Newsdesk www.benzinga.com Negative 47.3%

Neg 47.3% Neu 0% Pos 0%

Steris (NYSE:STE) widens FY2027 Adj EPS guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 analyst estimate. Affirms FY2027 sales outlook from $6.352 billion-$6.411 billion to $6.352 billion-$6.411 billion vs $6.371 billion estimate.